Global Nuclear Medicine Isotope Market Report to 2027 – Including Bayer, Bracco Imaging and Cardinal Health

DUBLIN, 09 May 2022–(BUSINESS WIRE)–The “Global Nuclear Medicine Isotopes Market 2021-2027” report has been added to ResearchAndMarkets.com’s offer.

The global nuclear medicine isotope market is projected to grow at a significant CAGR during the forecast period.

The increasing use of nuclear medicine isotopes in the treatment of various conditions is a key factor driving the growth of the global nuclear medicine isotope market. Nuclear medicine is used to diagnose and test the effect of a wide variety of diseases, including heart disease, tumors, gastrointestinal, neurological and endocrine disorders, as well as other abnormalities in the body.

The global nuclear medicine isotope market is segmented by type and application. By type, the market is segmented into stable isotopes and radioisotopes. On the basis of application, the nuclear medicine isotope market is segmented into nuclear therapy, equipment radioactive sources, and diagnosis.

Geographically, the global nuclear medicine isotope market includes the analysis of four major regions, including North America (US and Canada), Europe (UK, Germany, Italy, Spain, France, and rest of Europe), Asia-Pacific (China, Japan, India and the rest of Asia-Pacific), and the rest of the world. Some of the companies operating in the global nuclear medicine isotope market include Bayer AG, General Electric Co., Siemens Healthcare, Cardinal Health, Inc. and Nordion Inc.

Market share

The report covers

  • Comprehensive research methodology of the global nuclear medicine isotopes market.

  • This report also includes a detailed and comprehensive market overview with key analyst insights.

  • A comprehensive analysis of macro and micro factors influencing the market, guided by key recommendations.

  • Analysis of regional regulations and other government policies affecting the global nuclear medicine isotope market.

  • – Insights about market determinants driving the global nuclear medicine isotope market.

  • Detailed and comprehensive market segments with the regional distribution of the expected sales.

  • Extensive profiles and recent developments of market parties.

Main topics covered:

1. Report overview

1.1. Research Methods and Tools

1.2. Market sharing

1.2.1. By segments

1.2.2. per region

2. Market overview and insights

2.1. Scope of the report

2.2. Analyst insight and current market trends

2.2.1. Key findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Market determinants

3.1. motivators

3.2. limits

3.3. Opportunities

4. Market Segmentation

4.1. Global Nuclear Medicine Isotopes Market Segment By Type:

4.1.1. Stable isotopes

4.1.2. Radioisotopes

4.2. Global Nuclear Medicine Isotope Market Segment By Application: Introduction

4.2.1. Nuclear therapy

4.2.2. Equipment Radioactive Source

4.2.3. Diagnosis

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. Rest of Asia-Pacific

5.4. Rest of the world

6. Company Profiles

6.1. Advanced Accelerator Applications

6.2. Bayer AG

6.3. Bracco imaging

6.4. Cardinal Health, Inc.

6.5. Curium

6.6. Eczacybay-Monrol Nuclear Products

6.7 GE Healthcare

6.8. Lantheus medical imaging

6.9. Nordion

6.10. NTP Radioisotopes

For more information on this report, please visit https://www.researchandmarkets.com/r/ee00sy

Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220509005548/en/

Contacts

ResearchAndMarkets.com
Laura Wood, senior press manager
press@researchandmarkets.com
For EST business hours, call 1-917-300-0470
For USA/CAN Toll Free Call 1-800-526-8630
For GMT office hours, please call +353-1-416-8900

Leave a Comment